Mathew Blackman
Stock Analyst at Stifel
(1.24)
# 1506
Out of 5,319 analysts
64
Total ratings
50.00%
Success rate
9.07%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro | Maintains: Strong Buy | 19 25 | 12.25 | 104.08% | 3 | Apr 1, 2025 | |
BBNX Beta Bionics | Initiates Coverage On: Buy | 25 | 11.14 | 124.42% | 1 | Feb 24, 2025 | |
PODD Insulet | Maintains: Hold | 245 293 | 246.94 | 18.65% | 3 | Feb 21, 2025 | |
GMED Globus Medical | Maintains: Strong Buy | 92 94 | 71.01 | 32.38% | 5 | Feb 21, 2025 | |
OFIX Orthofix Medical | Upgrades: Buy | 18 24 | 13.01 | 84.47% | 5 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 3 | 1.3 | 130.77% | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 238 | 276.68 | -13.98% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 50 | n/a | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 90 100 | 68.62 | 45.73% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 16 | 10.54 | 51.8% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 55 60 | 16.86 | 255.87% | 5 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 6 7 | 6.8 | 2.94% | 11 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 18 11 | 7.78 | 41.39% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 | n/a | n/a | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 16 | n/a | n/a | 2 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 64 | n/a | n/a | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 | n/a | n/a | 2 | Aug 26, 2020 |